{
    "clinical_study": {
        "@rank": "16657", 
        "acronym": "CHAB", 
        "arm_group": {
            "arm_group_label": "Atenolol-Bisoprolol", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "At hemodynamic level, the greater affinity of bisoprolol by the beta 1 receptor in theory\n      could improve the peripheral arterial perfusion and could have a greater antihypertensive\n      effect. At the same time, this could carry objectifiable improvements in the vascular tree,\n      such as the level of arterial stiffness.\n\n      This study attempts to mark the hemodynamic differences in the same individual with\n      hypertension and metabolic syndrome who will be exposed to both drugs at different moments.\n      Parameters will be objectified with impedance cardiography, pulse wave velocity and central\n      blood pressure assessment before and after taking each one of the drugs. The results will be\n      compared to the baseline data and between themselves."
        }, 
        "brief_title": "Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Metabolic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Hypertension\n\n          -  Metabolic syndrome\n\n        Exclusion Criteria:\n\n          -  Severe hypertension >180/110\n\n          -  Secondary hypertension\n\n          -  Contraindication for betablockers\n\n          -  Prior treatment with betablockers (up to one month before inclusion)\n\n          -  History of neoplastic disease\n\n          -  Patients that do not sign informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01939509", 
            "org_study_id": "1445"
        }, 
        "intervention": [
            {
                "arm_group_label": "Atenolol-Bisoprolol", 
                "description": "Crossover (atenolol 25-50 mg, bisoprolol 2.5-5 mg)", 
                "intervention_name": "Atenolol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Atenolol-Bisoprolol", 
                "intervention_name": "Bisoprolol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Atenolol", 
                "Bisoprolol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 10, 2013", 
        "location": [
            {
                "contact": {
                    "email": "lucas.aparicio@hospitalitaliano.org.ar", 
                    "last_name": "Lucas S Aparicio, MD", 
                    "phone": "(005411)49590200", 
                    "phone_ext": "8567"
                }, 
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "C1181ACH"
                    }, 
                    "name": "Hospital Italiano de Buenos Aires"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lucas.aparicio@hospitalitaliano.org.ar", 
                    "last_name": "Lucas S Aparicio, MD", 
                    "phone": "49590200"
                }, 
                "contact_backup": {
                    "email": "diego.giunta@hospitalitaliano.org.ar", 
                    "last_name": "Diego Giunta, MD", 
                    "phone": "49590200", 
                    "phone_ext": "4419"
                }, 
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina"
                    }, 
                    "name": "Hospital Italiano de Buenos Aires"
                }, 
                "investigator": {
                    "last_name": "Lucas Aparicio", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lucas aparicio, MD", 
                    "phone": "49590200"
                }, 
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "c118ach"
                    }, 
                    "name": "Hospital Italiano de Buenos Aires"
                }, 
                "investigator": {
                    "last_name": "Lucas S Aparicio, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Argentina"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparison of the Hemodynamic Changes in Patients Under Treatment With Bisoprolol Versus Atenolol", 
        "overall_official": {
            "affiliation": "Hospital Italiano de Buenos Aires", 
            "last_name": "Gabriel D Waisman, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "central blood pressure", 
            "safety_issue": "No", 
            "time_frame": "two months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01939509"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Italiano de Buenos Aires", 
            "investigator_full_name": "Lucas Aparicio", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "peripheral resistance", 
                "safety_issue": "No", 
                "time_frame": "two months"
            }, 
            {
                "measure": "cardiac index", 
                "safety_issue": "No", 
                "time_frame": "two months"
            }, 
            {
                "measure": "pulse wave velocity", 
                "safety_issue": "No", 
                "time_frame": "two months"
            }
        ], 
        "source": "Hospital Italiano de Buenos Aires", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Italiano de Buenos Aires", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}